Phase II Study of RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer

Trial Profile

Phase II Study of RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Oct 2014

At a glance

  • Drugs Everolimus (Primary)
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Nov 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
    • 03 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Jun 2008 Status changed from recruiting to in progress, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top